Ulcerative ColitisCrohn Disease
Probiotics are live microorganisms that provide health benefits when consumed in sufficient amounts. Traditional probiot…
Roma, ItalyEst. completion Sep 14, 2026
Crohn Disease
Crohn's Disease (CD) is an inflammatory bowel disease. It can lead to significant complications and discomfort in the st…
New York, United StatesEst. completion Oct 2028
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
This research is studying whether changing an individual's behaviors may have an impact as a treatment or outcome for in…
Ann Arbor, United StatesEst. completion Mar 2028
Moderately to Severely Active Crohns Disease
This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety …
Dothan, United StatesEst. completion Dec 31, 2028
Ulcerative ColitisCrohn's Disease
Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (…
Birmingham, United StatesEst. completion Oct 1, 2027
Crohn Disease (CD)Crohn Disease
This study is investigating whether a cranberry-based dietary supplement, rich in polyphenols and fiber, can enhance gut…
Worcester, United StatesEst. completion Aug 15, 2026
Inflammatory Bowel DiseasesCrohn's Disease
This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety o…
Lancaster, United StatesEst. completion Sep 2028
Colitis, UlcerativeCrohn Disease
Study IIBD is a master protocol that will support a collection of individual sub studies that share key design component…
Scottsdale, United StatesEst. completion Jun 2027
Ulcerative Colitis (UC)Crohn Disease
In view of the increasing evidence of the importance of mucosal healing as a combination of endoscopic and histologic he…
San Donato Milanese, ItalyEst. completion Feb 2027
Inflammatory Bowel DiseaseUlcerative ColitisChrohn's Disease
This study will investigate in patients with Crohn s disease and ulcerative colitis how the body s immune system control…
Bethesda, United States
Crohn Disease
The main purpose of this study is to see how the safety and efficacy of a farnesoid X receptor (FXR) agonist (LY4395089)…
Scottsdale, United StatesEst. completion Jun 2027
IBDCrohn Disease (CD)Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Ultra Processed FoodNutrition AssessmentDGBI
This study explores whether simple nutrition education can help children and teens with inflammatory bowel disease (IBD)…
Hartford, United StatesEst. completion Dec 1, 2026
Crohn Disease
This is an open-label, single-arm, phase 4 study to assess the safety and efficacy of mirikizumab in approximately 60 pa…
Orlando, United StatesEst. completion Sep 1, 2027
Crohn's Disease (CD)Dysmenorrhea Primary
The purpose of this pilot study is to prepare for a larger study that will compare the effectiveness and safety of two c…
Chapel Hill, United StatesEst. completion Jul 2028
Moderately to Severely Active Crohns Disease
This phase III, double-blind, multi-center treat-through study will evaluate the efficacy and safety of Afimkibart (also…
Parkville, AustraliaEst. completion May 31, 2030
Crohn's Disease
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to s…
Dothan, United StatesEst. completion Oct 30, 2028
Inflamatory Bowel DiseaseCrohn Disease (CD)
This retrospective cohort study aims to compare the efficacy of different biologics in preventing postoperative endoscop…
Shanghai, ChinaEst. completion Sep 30, 2026
Crohn Disease
This study will test the safety and effectiveness of fecal microbiota transplantation (FMT) plus partial enteral nutriti…
Wuhan, ChinaEst. completion May 31, 2027
Crohn Disease
To explore the safety and effectiveness of repeated and multiple fecal microbiota transplantations (FMTs) plus partial e…
Wuhan, ChinaEst. completion Jun 30, 2027
Crohn Disease
The management of stricturing Crohn's disease (CD) remains challenging. Although surgical resection may be the final way…
Nanjing, ChinaEst. completion Jul 1, 2026